Genmab
GMAB
#1389
Rank
C$18.13 B
Marketcap
$28.49
Share price
-1.19%
Change (1 day)
-29.63%
Change (1 year)

Earnings for Genmab (GMAB)

Earnings in 2024 (TTM): C$1.82 Billion

According to Genmab's latest financial reports the company's current earnings are C$3.10 Billion. , an increase over its 2023 earnings that were of C$1.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Genmab from 2009 to 2024

Annual earnings

Year Earnings Change
2024 C$1.88 B63.99%
2023 C$1.14 B-17.29%
2022 C$1.38 B55.87%
2021 C$0.89 B-31.09%
2020 C$1.29 B111.51%
2019 C$0.61 B69.44%
2018 C$0.36 B49.63%
2017 C$0.24 B3.27%
2016 C$0.23 B46.33%
2015 C$0.15 B117.13%
2014 C$73.42 M329.17%
2013 C$17.1 M-159.26%
2012 -C$28.87 Million-48.96%
2011 -C$56.57 Million90.86%
2010 -C$29.64 Million-67.46%
2009 -C$91.09 Million